E-mail this page: News Release
Osiris Receives Second Approval for Life-Saving Stem Cell Drug; Prochymal Granted Marketing Consent by New Zealand
To (e-mail address):
Separate multiple addresses with commas. Maximum 200 characters.
Your name:
Your e-mail address:
Copy yourself
These e-mail addresses will be used to e-mail the page on your behalf and will not be used by Osiris Therapeutics for any marketing purposes.
Add a comment:
Send:
Full page
Link to page
Type in number:
This helps Osiris Therapeutics prevent automated submissions.
